Corrigendum: Delaying iron therapy until 28 days after antimalarial treatment is associated with greater iron incorporation and equivalent hematologic recovery after 56 days in children: A randomized controlled Trial (Journal of Nutrition (2016) 146 (1769-1774) DOI: 10.3945/jn.116.233239);Delaying Iron therapy until 28 days after antimalarial treatment is associated with greater Iron incorporation and equivalent hematologic recovery after 56 days in children: A randomized controlled trial

Journal of Nutrition

Volumn 146, Issue 9, 2016, Pages 1769-1774

  Cusick, Sarah E ^a   Opoka, Robert O ^b   Abrams, Steven A ^c   John, Chandy C ^d   Georgieff, Michael K ^a   Mupere, Ezekiel ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Iron; Iron stable isotopes; Malaria; Timing of iron therapy; Uganda

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; C REACTIVE PROTEIN; FERRITIN; FERROUS SULFATE; HEME; HEMOGLOBIN; HEPCIDIN; IRON; IRON 57; IRON 58; PROTOPORPHYRIN ZINC; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PROTOPORPHYRIN;

ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; IRON BLOOD LEVEL; IRON THERAPY; MAJOR CLINICAL STUDY; MALARIA; MALE; RANDOMIZED CONTROLLED TRIAL; UGANDA; ANEMIA, IRON-DEFICIENCY; BLOOD; COMPLICATION; DIETARY SUPPLEMENT; FOLLOW UP; INFLAMMATION; METABOLISM; PRESCHOOL CHILD;

ANEMIA, IRON-DEFICIENCY; ANTIMALARIALS; BIOMARKERS; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; ERYTHROCYTES; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMOGLOBINS; HEPCIDINS; HUMANS; INFANT; INFLAMMATION; IRON; IRON ISOTOPES; MALARIA; MALE; PROTOPORPHYRINS; RECEPTORS, TRANSFERRIN;

EID: 84988354654     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/nxz073     Document Type: Erratum

References (17)

1. Sazawal S, Black RE, Ramsan M, Chwaya HM, Dutta A, Dhingra U, Stoltzfus RJ, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006;367:133-43.
2. Gwamaka M, Kurtis JD, Sorensen BE, Holte S, Morrison R, Mutabingwa TK, Fried M, Duffy PE. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin Infect Dis 2012;54:1137-44.
3. Nyakeriga AM, Troye-Blomberg M, Dorfman JR, Alexander ND, Bäck R, Kortok M, Chemtai AK, Marsh K,Williams TN. Iron deficiency andmalaria among children living on the coast of Kenya. J Infect Dis 2004;190:439-47.
4. Cusick SE, Georgieff MK. Nutrient supplementation and neurodevelopment: timing is the key. Arch Pediatr Adolesc Med 2012;166:481-2.
5. Wachs TD, Georgieff M, Cusick S, McEwen BS. Issues in the timing of integrated early interventions: contributions from nutrition, neuroscience, and psychological research. Ann N YAcad Sci 2014;1308:89-106.
6. World Health Organization. Conclusions and recommendations of the WHO Consultation on prevention and control of iron deficiency in infants and young children in malaria-endemic areas. Food Nutr Bull 2007;28(4 Suppl):S621-7.
7. Desai MR, Mei JV, Kariuki SK, Wannemuehler KA, Phillips-Howard PA, Nahlen BL, Vulule JM, ter Kuile FO. Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxinepyramethamine for the treatment of mild childhood anemia in western Kenya. J Infect Dis 2003;187:658-66.
8. Nwanyanwu OC, Ziba C, Kazembe PN, Gamadzi G, Gandwe J, Redd SC. The effect of oral iron therapy during treatment for Plasmodium falciparum malaria with sulphadoxine-pyramethamine on Malawian children under 5 years of age. Ann Trop Med Parasitol 1996;90:589-95.
9. Verhoef H, West CE, Nzyuko SM, de Vogel S, van der Valk R, Wanga MA, Kuijsten A, Veenemans J, Kok FJ. Intermittent administration of iron and sulfadoxine-pyramethamine to control anaemia in Kenyan children: a randomised controlled trial. Lancet 2002;360:908-14.
10. Doherty CP, Cox SE, Fulford AJ, Austin S, Hilmers DC, Abrams SA, Prentice AM. Iron incorporation and post-malaria anaemia. PLoS One 2008;3:e2133.
11. Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 2012;119:1922-8.
12. de Mast Q, Nadjm B, Reyburn H, Kemna EH, Amos B, Laarakkers CM, Silalya S, Verhoef H, Sauerwein RW, Swinkels DW, et al. Assessment of urinary concentrations of hepcidin provides novel insight into disturbances in iron homeostasis during malarial infection. J Infect Dis 2009;199:253-62.
13. Abrams SA. Using stable isotopes to assess mineral absorption and utilization by children. Am J Clin Nutr 1999;70:955-64.
14. World Health Organization [Internet]. Basel: The WHO Child Growth Standards [cited 2016 Feb 18]. Available from: http://www.who.int/ childgrowth/standards/en/.
15. Glinz D, Kamiyango M, Phiri KS,Munthali F, Zeder C, Zimmermann MB, Hurrell RF, Wegmüller R. The effect of timing of iron supplementation on iron absorption and haemoglobin in post-malaria anaemia: a longitudinal stable isotope study in Malawian toddlers. Malar J 2014;13:397.
16. Glinz D, Hurrell RF, Righetti AA, Zeder C, Adiossan LG, Tjalsma H, Utzinger J, Zimmermann MB, N'Goran E, Wegmüller R. In Ivorian school-age children, infection with hookworm does not reduce dietary iron absorption or systemic iron utilization, whereas afebrile Plasmodium falciparum infection reduces iron absorption by half. Am J Clin Nutr 2015;101:462-70.
17. Cusick SE, Opoka RO, Ssemata AS, Georgiegg MK, John CC. Comparison of iron status 28 d after provision of antimalarial treatment with iron therapy compared with antimalarial treatment alone in Ugandan children with severe malaria. Am J Clin Nutr 2016;103:919-25.